Background There are conflicting reports on the factors that increase the likelihood of
patients dying from follicular thyroid carcinoma (FTC). Therefore, it is critical to identify risk …

Background Recurrence is a key outcome to evaluate treatment effect of differentiated
thyroid carcinoma (DTC). However, no consistent definition of recurrence is available in …

Background Research has shown that the disordered serum lipid profile may be associated
with the risk of differentiated thyroid cancer (DTC). Whether this association reflect causal …

Background The prognostic value of lymph node ratio (LNR) has been proved in several
cancers. However, the potential of LNR to be a prognostic factor for thyroid cancer has not …

Purpose: Aberrant DNA methylation plays a crucial role in the tumorigenesis of differentiated
thyroid cancer (DTC); nevertheless, the factors leading to the local and regional recurrence …

Regional lymph node metastasis (LNM) increases the risk of distant metastasis in papillary
thyroid cancer (PTC) patients. However, it remains unclear how tumor cells in PTC patients …

Objective Thyroid cancer is one of the most frequently reported endocrine system
malignancies. It is difficult to distinguish follicular thyroid cancer (FTC) from follicular thyroid …

Occult nodal spread and metastatic disease require longstanding imaging and biochemical
assessments for thyroid cancer, a disease that has a propensity for diffuse, small-volume …

Objective Recurrence of differentiated thyroid cancer (DTC) is associated with reduced
quality of life, and therefore, early identification of patients at risk is urgently needed. Here …

Background Follicular thyroid carcinoma (FTC) in adolescents and young adults (AYAs) is
rare and data on long‐term oncological outcomes are scarce. This study aimed to describe …